Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.
暂无分享,去创建一个
R. Martins | J. Foster | M. House | T. S. St. Pierre | R. Clarnette | J. Foster | M J House | T G St Pierre | J K Foster | R N Martins | R Clarnette | T. S. Pierre | R. Clarnette
[1] F. Gonzalez-Lima,et al. Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior☆ , 2000, Neurobiology of Aging.
[2] Mark A. Smith,et al. Iron: A Pathological Mediator of Alzheimer Disease? , 2002, Developmental Neuroscience.
[3] W. D. Ehmann,et al. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.
[4] A Brun,et al. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. , 1988, Brain : a journal of neurology.
[5] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[6] R Stewart,et al. Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study , 2001, Neurology.
[7] V. Haughton,et al. T1 and T2 measurements on a 1.5-T commercial MR imager. , 1989, Radiology.
[8] G. Bartzokis,et al. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.
[9] J. Lucas,et al. Disorders of memory. , 2005, The Psychiatric clinics of North America.
[10] R. Bakshi,et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.
[11] Jane S. Paulsen,et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.
[12] D. Schubert,et al. The role of iron in beta amyloid toxicity. , 1995, Biochemical and biophysical research communications.
[13] Jim Mintz,et al. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI , 1994, Biological Psychiatry.
[14] Craig K. Jones,et al. Normal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2 , 2002, Magnetic resonance in medicine.
[15] G. Bartzokis,et al. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. , 2003, Archives of neurology.
[16] Huali Wang,et al. Prolongation of T2 relaxation times of hippocampus and amygdala in Alzheimer's disease , 2004, Neuroscience Letters.
[17] J. Bulte,et al. Comparison of t2 relaxation in blood, brain, and ferritin , 1995, Journal of magnetic resonance imaging : JMRI.
[18] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Neary,et al. Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias , 2002, Acta neurologica Scandinavica.
[20] Yu-Min Kuo,et al. Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .
[21] G. Bartzokis. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.
[22] P. Mantyh,et al. Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.
[23] G. Brittenham,et al. Noninvasive measurement of iron: report of an NIDDK workshop. , 2003, Blood.
[24] J. Connor,et al. Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.
[25] Hisashi Tanaka,et al. Determination of transverse relaxation rate for estimating iron deposits in central nervous system , 2005, Neuroscience Research.
[26] K. Krishnan,et al. Quantitative analysis of T2 signal intensities in Alzheimer's Disease , 1998, Psychiatry Research: Neuroimaging.
[27] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[28] H. Braak,et al. Alzheimer's disease affects limbic nuclei of the thalamus , 2004, Acta Neuropathologica.
[29] A Brun,et al. CORRELATIONS BETWEEN HISTOPATHOLOGIC WHITE MATTER CHANGES AND PROTON MR RELAXATION TIMES IN DEMENTIA , 1987, Alzheimer disease and associated disorders.
[30] M. Kopelman. Disorders of memory. , 2002, Brain : a journal of neurology.
[31] C. Morris,et al. Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.
[32] Larry L. Butcher,et al. Prolongation of magnetic resonance T 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease , 1992, Neuroscience Letters.
[33] K. Kristensson,et al. Lipid Composition in Different Regions of the Brain in Alzheimer's Disease/Senile Dementia of Alzheimer's Type , 1992, Journal of neurochemistry.
[34] S. M. de la Monte,et al. Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.
[35] P. Scheltens,et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.
[36] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[37] J. O'Brien,et al. Comparison of the pathology of cerebral white matter with post‐mortem magnetic resonance imaging (MRI) in the elderly brain , 2004, Neuropathology and applied neurobiology.
[38] P D Griffiths,et al. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. , 1993, Dementia.
[39] E. Englund,et al. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes , 2003, Neuropathology and applied neurobiology.
[40] P. Riekkinen,et al. 2′,3′-Cyclic nucleotide-3′-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease , 1989, Neuroscience Letters.
[41] H. Soininen,et al. Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease , 1996, Neurology.
[42] G A Johnson,et al. In vitro MR microscopy of the hippocampus in Alzheimer's disease , 1993, Neurology.
[43] J. Besson,et al. Post-mortem Proton Magnetic Resonance Spectrometric Measures of Brain Regions in Patients with a Pathological Diagnosis of Alzheimer's Disease and Multi-infarct Dementia , 1992, British Journal of Psychiatry.
[44] R. Brooks,et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.
[45] Stavros J. Baloyannis,et al. Mitochondrial alterations in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[46] G E Santyr,et al. Magnetization transfer effects in multislice MR imaging. , 1993, Magnetic resonance imaging.
[47] T. S. St. Pierre,et al. Single spin‐echo proton transverse relaxometry of iron‐loaded liver , 2004, NMR in biomedicine.
[48] Douglas Walker,et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. , 2002, Biochemistry.
[49] A. Delacourte,et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.
[50] Steven M LeVine,et al. Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.
[51] H. Soininen,et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment , 1996, Neurobiology of Aging.
[52] W. D. Ehmann,et al. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.
[53] C. Jack,et al. Hippocampal transverse relaxation times in patients with Alzheimer disease. , 1997, Radiology.
[54] W. D. Ehmann,et al. Regional brain trace-element studies in Alzheimer's disease. , 1988, Neurotoxicology.
[55] R A Knight,et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.